Article

Advances on Anti-Cancer Combination Therapies Targeting DNA Repair Pathway, Epigenetics, Microbiomes and the Immune System

2026-08-26

Abstract excerpt

Modern pipelines integrating multi-omics data, chemical libraries, structural biology information and artificial intelligence are currently accelerating drug discovery and precision medicine. Aligned with these advances, the multi-omics profiling technologies enable the identification of unique genetic and epigenetic signatures for stratification of patients based on cancer specific target and vulnerability. Targe...

Topics

Open a Topic to create a Post that cites this publication.

Uncategorized literature

Identifiers and source

Literature Corpus work: 02f02af4-c0f7-5d7d-bc10-c13b66ec04a2
DOI: 10.20944/preprints202608.1907.v1

Open publication

Related research

Semantic proximity does not establish scientific evidence. Graph snapshot: 2026-09-29.

Click a neighbor to travelStep 1 · 12 closest

Advances on Anti-Cancer Combination Therapies Targeting DNA Repair Pathway, Epigenetics, Microbiomes and the Immune SystemDOI 10.20944/preprints202608.1907.v1Read

Biology and Development of DNA-Targeted Drugs, Focusing on Synthetic Lethality, DNA Repair, and Epigenetic Modifications for Cancer: A ReviewSemantic proximity Read

Advancing cancer therapy: new frontiers in targeting DNA damage responseSemantic proximity Read

Error‐prone DNA repair pathways as determinants of immunotherapy activity: an emerging scenario for cancer treatmentSemantic proximity Read

DNA damage response, genetic instability and cancer: From mechanistic insights to personalized treatmentSemantic proximity Read

Genomics of response to immune checkpoint therapies for cancer: implications for precision medicineSemantic proximity Read

Cancer Vulnerabilities Through Targeting the ATR/Chk1 and ATM/Chk2 Axes in the Context of DNA DamageSemantic proximity Read

Wedding of Molecular Alterations and Immune Checkpoint Blockade: Genomics as a MatchmakerSemantic proximity Read

Molecular landscape and clinical translation of DNA damage response alterations in solid tumors: A pan-cancer perspective on precision oncology.Semantic proximity Read

Advances and prospects of biomarkers for immune checkpoint inhibitorsSemantic proximity Read

Evaluation of 30 DNA damage response and 6 mismatch repair gene mutations as biomarkers for immunotherapy outcomes across multiple solid tumor typesSemantic proximity Read

Impact of DNA damage response defects in cancer cells on response to immunotherapy and radiotherapy.Semantic proximity Read